Rethinking Market Strategy within a Patient-Centric Era

As the series closes, the panel reflects on an often underrepresented but crucial stakeholder: the patient. The discussion underscores the need for a more patient-centered market access strategy—one that incorporates health equity, diagnostic and treatment journey support, and clearer communication around cost and adherence.

Key discussion topics include:

• How social determinants of health (SDOH) shape real-world treatment access.
• The growing need for payer transparency and patient trust in the marketplace.
• Strategies to engage patients early in development to ensure success.